Clinical Efficacy of Topical CoQ۱۰ and Vitamin-E Eye-drop in Retinopathy of Prematurity
- سال انتشار: 1398
- محل انتشار: مجله نظریه پردازی در چشم پزشکی، دوره: 8، شماره: 4
- کد COI اختصاصی: JR_MEOP-8-4_006
- زبان مقاله: انگلیسی
- تعداد مشاهده: 57
نویسندگان
چکیده
Abstract Treatment strategy for retinopathy of prematurity (ROP) includes anti-vascular endothelial growth factor (anti-VEGF) and/or laser therapy. The aim of this study was to investigate the clinical effects of topical Coqun® eye drop (CoQ۱۰ and Vitamin-E) on the progression and treatment of ROP. One hundred and ten infants with type ۱ ROP who received Coqun® (Coqun group) and ۱۳۱ infants with type ۱ ROP who did not receive Coqun® (control group) were included in this retrospective analysis. All patients were follow-up until retinal vascular maturation was complete. Intravitreal bevacizumab (IVB) injection or laser photocoagulation (LPC) were apply if needed. Treatment frequency, treatment response and mean follow-up time were compare. The number of IVB was similar between the groups, but infants in the Coqun group underwent significantly fewer LPC procedure than those in the control group (P = ۰.۰۲۲). The mean follow-up time was significantly shorter in infants receiving Coqun® in stage ۱ ROP (P = ۰.۰۱۷) and similar in stages ۲-۴ ROP and aggressive posterior retinopathy of prematurity (APROP). The number of LPC procedure was fewer in the Coqun group in APROP (P = ۰.۰۴۳). These results indicate that faster retinal vascular maturation in infants with low-grade ROP and lower number of treatments with APROP could be achieve with Coqun® therapy. Epub: October ۱, ۲۰۱۹.کلیدواژه ها
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.